Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FermenGIN is a South Korean biotechnology company specializing in the development of high-efficacy functional materials through advanced microbial fermentation processes. The company focuses on transforming traditional natural ingredients, particularly ginseng, into highly bioavailable compounds such as rare ginsenosides using proprietary fermentation technology. Their product portfolio includes functional food ingredients and health supplements designed to enhance immune function, reduce fatigue, and improve cognitive health. By leveraging bioconversion techniques, FermenGIN aims to maximize the therapeutic potential of natural substances for the global healthcare and nutraceutical markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FermenGIN.